Researchers found low rates of patient involvement in first-line ovarian cancer treatment decisions in Europe and the US from 2017 to 2020 despite the increasing use of targeted therapies, like poly ...
Deshpandé, Rohit, Wayne D. Hoyer, and Scott Jeffries. "Low Involvement Decision Processes: The Importance of Choice Tactics." Proceedings Series, American Marketing Association (1982): 155–158.